Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine

Shirley Jankelevich, Brigitta U. Mueller, Crystal L. Mackall, Sharon Smith, Sheryl Zwerski, Lauren V. Wood, Steven L. Zeichner, Leslie Serchuck, Seth M. Steinberg, Robert Nelson, John W. Sleasman, Bach Yen Nguyen, Philip A. Pizzo, Robert Yarchoan

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Virologic and immunologic responses were examined for 33 human immunodeficiency virus (HIV)-infected children who participated for ≥96 weeks in a phase 1/2 protocol of 16 weeks of indinavir monotherapy, followed by the addition of zidovudine and lamivudine. At week 96, a median increase of 199 CD4+T cells/μL and a median decrease of 0.74 log10HIV RNA copies/mL were observed. The relationship between control of viral replication and CD4+T cell count was examined. Patients were categorized into 3 response groups on the basis of duration and extent of control of viral replication. Of 21 children with a transient decrease in virus load of ≥0.7 log10HIV RNA copies/mL from baseline, 7 experienced sustained increases in CD4+, CD4+CD45RA+, and CD4+CD45RO+T cell counts. CD4+CD45RA+(naive) T cells were the major contributor to CD4+T cell expansion. Continued long-term immunologic benefit may be experienced by a subset of children, despite only transient virologic suppression.

Original languageEnglish (US)
Pages (from-to)1116-1120
Number of pages5
JournalJournal of Infectious Diseases
Volume183
Issue number7
DOIs
StatePublished - Apr 1 2001
Externally publishedYes

Fingerprint

Indinavir
Lamivudine
Zidovudine
HIV-1
T-Lymphocytes
RNA
CD4 Lymphocyte Count
Cell Count
HIV
Viruses

ASJC Scopus subject areas

  • Immunology and Allergy
  • Medicine(all)
  • Infectious Diseases

Cite this

Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine. / Jankelevich, Shirley; Mueller, Brigitta U.; Mackall, Crystal L.; Smith, Sharon; Zwerski, Sheryl; Wood, Lauren V.; Zeichner, Steven L.; Serchuck, Leslie; Steinberg, Seth M.; Nelson, Robert; Sleasman, John W.; Nguyen, Bach Yen; Pizzo, Philip A.; Yarchoan, Robert.

In: Journal of Infectious Diseases, Vol. 183, No. 7, 01.04.2001, p. 1116-1120.

Research output: Contribution to journalArticle

Jankelevich, S, Mueller, BU, Mackall, CL, Smith, S, Zwerski, S, Wood, LV, Zeichner, SL, Serchuck, L, Steinberg, SM, Nelson, R, Sleasman, JW, Nguyen, BY, Pizzo, PA & Yarchoan, R 2001, 'Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine', Journal of Infectious Diseases, vol. 183, no. 7, pp. 1116-1120. https://doi.org/10.1086/319274
Jankelevich, Shirley ; Mueller, Brigitta U. ; Mackall, Crystal L. ; Smith, Sharon ; Zwerski, Sheryl ; Wood, Lauren V. ; Zeichner, Steven L. ; Serchuck, Leslie ; Steinberg, Seth M. ; Nelson, Robert ; Sleasman, John W. ; Nguyen, Bach Yen ; Pizzo, Philip A. ; Yarchoan, Robert. / Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine. In: Journal of Infectious Diseases. 2001 ; Vol. 183, No. 7. pp. 1116-1120.
@article{5609d3f673a040f1896ade00092fb015,
title = "Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine",
abstract = "Virologic and immunologic responses were examined for 33 human immunodeficiency virus (HIV)-infected children who participated for ≥96 weeks in a phase 1/2 protocol of 16 weeks of indinavir monotherapy, followed by the addition of zidovudine and lamivudine. At week 96, a median increase of 199 CD4+T cells/μL and a median decrease of 0.74 log10HIV RNA copies/mL were observed. The relationship between control of viral replication and CD4+T cell count was examined. Patients were categorized into 3 response groups on the basis of duration and extent of control of viral replication. Of 21 children with a transient decrease in virus load of ≥0.7 log10HIV RNA copies/mL from baseline, 7 experienced sustained increases in CD4+, CD4+CD45RA+, and CD4+CD45RO+T cell counts. CD4+CD45RA+(naive) T cells were the major contributor to CD4+T cell expansion. Continued long-term immunologic benefit may be experienced by a subset of children, despite only transient virologic suppression.",
author = "Shirley Jankelevich and Mueller, {Brigitta U.} and Mackall, {Crystal L.} and Sharon Smith and Sheryl Zwerski and Wood, {Lauren V.} and Zeichner, {Steven L.} and Leslie Serchuck and Steinberg, {Seth M.} and Robert Nelson and Sleasman, {John W.} and Nguyen, {Bach Yen} and Pizzo, {Philip A.} and Robert Yarchoan",
year = "2001",
month = "4",
day = "1",
doi = "10.1086/319274",
language = "English (US)",
volume = "183",
pages = "1116--1120",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine

AU - Jankelevich, Shirley

AU - Mueller, Brigitta U.

AU - Mackall, Crystal L.

AU - Smith, Sharon

AU - Zwerski, Sheryl

AU - Wood, Lauren V.

AU - Zeichner, Steven L.

AU - Serchuck, Leslie

AU - Steinberg, Seth M.

AU - Nelson, Robert

AU - Sleasman, John W.

AU - Nguyen, Bach Yen

AU - Pizzo, Philip A.

AU - Yarchoan, Robert

PY - 2001/4/1

Y1 - 2001/4/1

N2 - Virologic and immunologic responses were examined for 33 human immunodeficiency virus (HIV)-infected children who participated for ≥96 weeks in a phase 1/2 protocol of 16 weeks of indinavir monotherapy, followed by the addition of zidovudine and lamivudine. At week 96, a median increase of 199 CD4+T cells/μL and a median decrease of 0.74 log10HIV RNA copies/mL were observed. The relationship between control of viral replication and CD4+T cell count was examined. Patients were categorized into 3 response groups on the basis of duration and extent of control of viral replication. Of 21 children with a transient decrease in virus load of ≥0.7 log10HIV RNA copies/mL from baseline, 7 experienced sustained increases in CD4+, CD4+CD45RA+, and CD4+CD45RO+T cell counts. CD4+CD45RA+(naive) T cells were the major contributor to CD4+T cell expansion. Continued long-term immunologic benefit may be experienced by a subset of children, despite only transient virologic suppression.

AB - Virologic and immunologic responses were examined for 33 human immunodeficiency virus (HIV)-infected children who participated for ≥96 weeks in a phase 1/2 protocol of 16 weeks of indinavir monotherapy, followed by the addition of zidovudine and lamivudine. At week 96, a median increase of 199 CD4+T cells/μL and a median decrease of 0.74 log10HIV RNA copies/mL were observed. The relationship between control of viral replication and CD4+T cell count was examined. Patients were categorized into 3 response groups on the basis of duration and extent of control of viral replication. Of 21 children with a transient decrease in virus load of ≥0.7 log10HIV RNA copies/mL from baseline, 7 experienced sustained increases in CD4+, CD4+CD45RA+, and CD4+CD45RO+T cell counts. CD4+CD45RA+(naive) T cells were the major contributor to CD4+T cell expansion. Continued long-term immunologic benefit may be experienced by a subset of children, despite only transient virologic suppression.

UR - http://www.scopus.com/inward/record.url?scp=0035312995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035312995&partnerID=8YFLogxK

U2 - 10.1086/319274

DO - 10.1086/319274

M3 - Article

VL - 183

SP - 1116

EP - 1120

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 7

ER -